We anticipate the application window for this opening will close on - 23 Oct 2026

Careers that change lives start here. Medtronic is a global leader in healthcare technology with a Mission to alleviate pain, restore health, and extend life. Our 95,000 employees work across more than 150 countries to put patients first — developing innovative medical technologies that improve the lives of 72+ million patients each year. Your unique talents will help shape the future of healthcare while building a career grounded in purpose, growth, and impact.

A Day in the Life

Medtronic’s HR Shared Services Team is helping define the future of HR by delivering scalable, high-quality support that enhances the employee experience and drives operational excellence. The team executes standardized HR processes and partners across Human Resources, Payroll, Benefits, and external vendors to provide consistent, efficient service while advancing continuous improvement, automation, and process excellence.

This role is based at Medtronic’s headquarters in Minneapolis, Minnesota. The position follows a flexible work model with four days onsite and one day remote per week.

The HR Shared Services Specialist delivers employee support for benefits, leave, disability, and related HR programs while ensuring accurate transaction processing, strong data integrity, and a positive employee experience. This role partners across HR, Payroll, and external vendors to resolve issues, administer programs, support compliance activities, and identify opportunities to improve processes, systems, and service delivery.

Primary Responsibilities

Administer U.S. health and welfare benefit programs, including medical, dental, vision, life insurance, accidental death and dismemberment (AD&D), Flexible Spending Accounts (FSA), and Health Savings Accounts (HSA).
Process employee benefit enrollments, qualifying life event changes, terminations, and related transactions with accuracy and timeliness.
Administer disability and leave programs, including Short-Term Disability (STD), Long-Term Disability (LTD), Family and Medical Leave Act (FMLA), and company leave policies.
Serve as an escalation point for employee and manager inquiries related to benefits, leave, disability, and time-off programs.
Partner with HR, Payroll, vendors, and third-party administrators to research, resolve, and communicate complex cases.
Audit transactions, records, and system data to ensure compliance, data integrity, and accurate processing.
Generate reports and support compliance reviews, documentation updates, testing activities, and HR projects.
Identify and implement process improvements, automation opportunities, and system enhancements that improve service delivery and operational efficiency.

Required Qualifications

High School Diploma or equivalent and 2+ years of experience in employee benefits, leave administration, disability programs, or HR service delivery processes OR an advanced degree.
Experience administering employee benefits, leave, or disability-related transactions.
Experience using Human Resources Information Systems (HRIS) and case management or benefits administration systems.
Experience working with confidential employee information while maintaining data accuracy and compliance.

Preferred Qualifications

Experience in an HR shared services environment supporting benefits and leave administration in a Tier II capacity.
Experience administering U.S. benefits and leave programs, including Employee Retirement Income Security Act (ERISA), Health Insurance Portability and Accountability Act (HIPAA), Consolidated Omnibus Budget Reconciliation Act (COBRA), FMLA, and Affordable Care Act (ACA) processes.
Experience with Workday, Microsoft Excel, and Microsoft Power Automate for reporting, workflow optimization, and automation.
Experience partnering with benefits carriers, third-party administrators, payroll teams, and external vendors to resolve complex employee issues.
Experience with process improvement initiatives, system testing, and creation of standard operating procedures, knowledge articles, or process documentation.

For Baccalaureate degrees earned outside of the United States, a degree that satisfies the requirements of 8 C.F.R. § 214.2(h)(4)(iii)(A) is required.

Physical Job Requirements

The above statements are intended to describe the general nature and level of work being performed by employees assigned to this position, but they are not an exhaustive list of all the required responsibilities and skills of this position. 

The physical demands described within the Responsibilities section of this job description are representative of those that must be met by an employee to successfully perform the essential functions of this job. Reasonable accommodations may be made to enable individuals with disabilities to perform the essential functions. For Office Roles: While performing the duties of this job, the employee is regularly required to be independently mobile. The employee is also required to interact with a computer, and communicate with peers and co-workers. Contact your manager or local HR to understand the Work Conditions and Physical requirements that may be specific to each role.

U.S. Work Authorization & Sponsorship

At Medtronic, we are committed to fostering an environment where employees can thrive and make a meaningful impact. In alignment with our enterprise-wide workforce planning approach, U.S. work authorization sponsorship (H-1B, TN, J, etc.) is offered exclusively for Principal-level roles and above, where specialized expertise aligns with long-term business needs. Roles below the Principal level require candidates to possess unrestricted U.S. work authorization at the time of hire and for the duration of employment.

‌

Recruitment Fraud Alert

We are aware of phishing scams targeting job seekers. Please keep the following in mind:

Apply only through official Medtronic channels. All legitimate Medtronic recruiting communications come from approved Medtronic platforms and official @medtronic.com email addresses.

Medtronic will never ask for payment or sensitive personal information (such as bank account or Social Security details) during early stages of the hiring process. Any such requests are not legitimate.

If you receive a suspicious message claiming to be from Medtronic, do not respond, click links, or open attachments.

If you have any questions, concerns regarding the authenticity of a communication alleged to have been made by or on behalf of Medtronic, please contact us immediately at [email protected].

‌

Benefits & Compensation

Medtronic offers a competitive Salary and flexible Benefits Package
A commitment to our employees lives at the core of our values. We recognize their contributions. They share in the success they help to create.We offer a wide range of benefits, resources, and competitive compensation plans designed to support you at every career and life stage.

Salary ranges for U.S (excl. PR) locations (USD):$64,000.00 - $96,000.00

‌

This position is eligible for a short-term incentive called the Medtronic Incentive Plan (MIP).The base salary range is applicable across the United States, excluding Puerto Rico and specific locations in California. The offered rate complies with federal and local regulations and may vary based on factors such as experience, certification/education, market conditions, and location. Compensation and benefits information pertains solely to candidates hired within the United States (local market compensation and benefits will apply for others).

The following benefits and additional compensation are available to those regular employees who work 20+ hours per week: Health, Dental and vision insurance,Health Savings Account,Healthcare Flexible Spending Account,Life insurance, Long-term disability leave,Dependent daycare spending account,Tuition assistance/reimbursement, andSimple Steps (global well-being program).

The following benefits and additional compensation are available to all regular employees:Incentive plans, 401(k) plan plus employer contribution and match,Short-term disability,Paid time off,Paid holidays,Employee Stock Purchase Plan,Employee Assistance Program,Non-qualified Retirement Plan Supplement (subject to IRS earning minimums), andCapital Accumulation Plan (available to Vice Presidents and above, or subject to IRS earning minimums).

Regular employees are those who are not temporary, such as interns. Temporary employees are eligible for paid sick time, as required under applicable state law, and the Employee Stock Purchase Plan. Please note some of the above benefits may not apply to workers in Puerto Rico.

Further details are available at the link below:

Medtronic benefits and compensation plans

It is the policy of Medtronic to provide equal employment opportunity (EEO) to all persons regardless of age, color, national origin, citizenship status, physical or mental disability, race, religion, creed, gender, sex, sexual orientation, gender identity and/or expression, genetic information, marital status, status with regard to public assistance, veteran status, or any other characteristic protected by federal, state or local law. In addition, Medtronic will provide reasonable accommodations for qualified individuals with disabilities.

If you are applying to perform work for Medtronic, Inc. (“Medtronic”) in any position which will involve performing at least two (2) hours of work on average each week within the unincorporated areas of Los Angeles County, you can find here a list of all material job duties of the specific job position which Medtronic reasonably believes that criminal history may have a direct, adverse and negative relationship potentially resulting in the withdrawal of a conditional offer of employment. Medtronic will consider for employment qualified job applicants with arrest or conviction records in accordance with the Los Angeles County Fair Chance Ordinance for Employers and the California Fair Chance Act.

About the company

Medtronic makes medical devices and therapies to treat chronic diseases, including implantables, sensors, and diabetes management tools. Its devices interact with the body to regulate or monitor functions, such as pacemakers delivering heart stimulation and neuromodulation devices sending electrical signals. The company differentiates itself through a long history of device development and a broad portfolio, expanded via acquisitions to access new technologies and markets. Its goal is to improve patient health outcomes by providing integrated medical technologies that help manage chronic conditions.

Company Size

10,001+

Company Stage

IPO

Headquarters

Fridley, Minnesota

Founded

1949

Get referred to Medtronic

See people who can refer or advise you

Simplify's Take

What believers are saying

Sept. 23, 2026 fiscal Q1 organic revenue rose 13.7%, led by Cardiac Ablation Solutions.
Sept. 30, 2026 Affera clearances deepen Medtronic's edge in pulsed field ablation.
Sept. 14, 2026 MiniMed exchange offer advances portfolio simplification and capital redeployment.

What critics are saying

July 15, 2026 Bio-Medicus recall exposed packaging failures in a high-risk perfusion product.
Medtronic spinal cord stimulator cases remain individual, and Schiltz's July 14, 2026 order tightens deadlines.
MiniMed separation still consumes management attention, and a weak public debut pressures execution through 2027.

What makes Medtronic unique

Sep 30, 2026 Prism-2 software tightly links Medtronic catheters, mapping, and PFA therapy.
Sept. 16, 2026 Hugo gained LigaSure robotic clearance, building a multi-platform surgical stack.
Oct. 1, 2026 Altaviva and Symplicity earned Category I CPT codes, accelerating reimbursement.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Health Savings Account/Flexible Spending Account
Unlimited Paid Time Off
Paid Vacation
Paid Sick Leave
Paid Holidays
401(k) Retirement Plan
401(k) Company Match

Growth & Insights and Company News

Headcount

6 month growth

-1%

1 year growth

2 year growth

PR Newswire

Oct 15th, 2026

Medtronic's Stealth AXiS surgical system and Corsano wearable named to TIME Best Inventions 2026

Medtronic plc has won a place on TIME's Best Inventions of 2026 list for two products: the Stealth AXiS surgical system and the Corsano multi-parameter wearable. The company announced the recognition on October 15, 2026. Stealth AXiS combines planning, navigation, and robotic-assisted execution in one platform. It supports spinal, cranial, and ear, nose, and throat procedures, and uses real-time data, advanced imaging, and AI. The Corsano wearable is made by Corsano Health B.V. and distributed by Medtronic in the US and Western Europe. It tracks pulse rate, blood oxygen saturation, respiration rate, skin temperature, and activity, giving clinicians near real-time data from hospital to home. Spot checks alone can leave patients unmonitored 96% of the time, according to the company.

SPINEMarketGroup

Oct 15th, 2026

Medtronic Named to TIME Best Inventions of 2026 List for Stealth AXiS(TM) surgical system and Corsano(TM)* multi-parameter wearable.

Medtronic Named to TIME Best Inventions of 2026 List for Stealth AXiS(TM) surgical system and Corsano(TM)* multi-parameter wearable. GALWAY, Ireland, Oct. 15, 2026 /PRNewswire/ - Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that the Stealth AXiS(TM) surgical system and the Corsano(TM)* multi-parameter wearable have been named to the TIME Best Inventions of 2026 list. The annual award highlights the most impactful new products and ideas of the year, assessed by TIME editors. The dual recognition highlights the Medtronic enterprise-wide commitment to transforming healthcare through connected technologies that help clinicians make more informed decisions and improve care delivery. Advancing connected surgery with Stealth AXiS(TM) The Stealth AXiS(TM) surgical system was recognized for bringing planning, navigation, and robotic-assisted execution together in a single platform designed for complex procedures. The system addresses challenges in surgery, where technologies for planning, imaging, navigation, and execution are often fragmented across multiple systems. Built within Medtronic's AiBLE(TM) smart ecosystem, the Stealth AXiS(TM) system supports spinal, cranial, and ear, nose, and throat (ENT) procedures by integrating real-time data, advanced imaging, and AI-based capabilities into the surgical workflow to create a more connected approach to care across the surgical journey. "Being named a TIME Best Invention is meaningful recognition of the innovation behind the Stealth AXiS(TM) system and our commitment to advancing the connected surgical ecosystem," said Michael Carter, president of the Cranial and Spinal Technologies operating unit within the Neuroscience Portfolio at Medtronic. "Our goal is to help surgical teams work with greater connectivity and intelligence by bringing planning, navigation, and robotics together in one integrated platform." Expanding continuous patient monitoring with Corsano(TM)* multi-parameter wearable The Corsano(TM)* multi-parameter wearable was recognized for its ability to extend clinical visibility beyond traditional bedside monitoring through a lightweight, tetherless wearable designed to capture key vital parameters and trending information to inform clinical decision making. Manufactured by Corsano Health B.V. and distributed in the U.S. and Western Europe by Medtronic, the wearable provides clinicians access to patient data in near real time, from the hospital to the home setting. While spot checking alone can leave patients unmonitored 96% of the time[1], the medical-grade wearable monitors pulse rate, blood oxygen saturation (SpO[2]), respiration rate, skin temperature, and activity, helping clinicians access timely patient information while enabling patient mobility and comfort. "This recognition on the TIME Best Inventions list is a testament to what's made possible by the next generation of patient monitoring," said Kate Benedict, president of the Acute Care & Monitoring operating unit within the Medical Surgical Portfolio at Medtronic. "The Corsano(TM)* multi-parameter wearable meaningfully expands our portfolio of wearable patient monitoring solutions and reflects our commitment to helping clinicians stay connected to patient data wherever care is delivered, enabling more informed decisions with patient insights." About Medtronic Bold thinking. Bolder actions. The Spine Market Group is Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Its Mission - to alleviate pain, restore health, and extend life - unites a global team of 95,000+ passionate people across more than 150 countries. Its technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, surgical tools, patient monitoring systems, and more. Powered by its diverse knowledge, insatiable curiosity, and desire to help all those who need it, The Spine Market Group deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from The Spine Market Group as The Spine Market Group empower insight-driven care, experiences that put people first, and better outcomes for its world. In everything The Spine Market Group do, The Spine Market Group is engineering the extraordinary. For more information on Medtronic, visit www.Medtronic.com and follow Medtronic on LinkedIn. About the Cranial & Spinal Technologies Business at Medtronic As the global market leader, Medtronic Cranial and Spinal Technologies is transforming the standard of care in spine and cranial surgery by putting patients first and addressing the complex challenges faced by spine and neurosurgeons. With a portfolio of 150 products covering more than 20 pathologies, The Spine Market Group serve over 4 million patients annually. Building on a legacy of innovation, its AiBLE(TM) ecosystem integrates advanced technologies, data, and AI with a patient-centric approach, offering customizable solutions to enhance surgical precision, improve workflow efficiency, and pursue better outcomes, before, during, and beyond surgery. About Acute Care & Monitoring At Medtronic Acute Care & Monitoring, The Spine Market Group put patients first by designing patient monitoring and airway management technologies that support care in the moments that matter. By simplifying clinical decision making, workflows, and operational performance, The Spine Market Group help care teams stay focused on patients while helping organizations create sustainable value from their technology investments. The Spine Market Group do this to support its vision: to enable personalized patient care, anytime, anywhere. For more information, visit medtronic.com/ACM. About the Ear, Nose, & Throat Business at Medtronic Medtronic's Ear, Nose, and Throat (ENT) business is the global market leader in ENT, delivering innovative technologies that impact nearly 3 million patients each year. For more than 25 years, The Spine Market Group has collaborated with physicians to advance care across the specialty. Its portfolio supports surgical procedures related to chronic rhinosinusitis and head and neck cancers, spanning surgical navigation, tissue health, powered instruments, localized drug delivery, intraoperative nerve monitoring, and parathyroid detection. As the global leader in ENT navigation since the introduction of the LandmarX(TM) image-guided surgery system in 1998, The Spine Market Group continue to advance the field with next-generation platforms including the Stealth AXiS(TM) Surgical System. For more information, visit Medtronic.com/AXiSENT. About Corsano Health Corsano Health B.V. is a leading MedTech company that creates, manufactures, and sells advanced real-time remote patient monitoring solutions. With a CE-MDR medically certified system and FDA clearance, the Corsano(TM) multi-parameter wearable is setting new standards for continuous monitoring, focusing on its mission to lower healthcare costs and support clinical teams in improving outcomes and patient experiences. For more information, visit https://corsano.com/. *The Corsano(TM)* multi-parameter wearable is manufactured by Corsano Health B. V. and distributed by Medtronic. The Corsano(TM) multi-parameter wearable should not be used as the sole basis for diagnosis or therapy and is intended only as an adjunct in patient assessment. It is not intended for use in high-acuity environments or on acutely ill cardiac patients with potential to develop life-threatening arrhythmias, or for SpO[2] monitoring in conditions of high motion or low perfusion. [1] Curry and Jungquist: A critical assessment of monitoring practices, patient deterioration, and alarm fatigue on inpatient wards: a review. Patient Safety in Surgery 2014 8:29. Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results. SOURCE Medtronic plc

Flywheel Publishing, LLC

Oct 14th, 2026

Medtronic pays more today. Abbott raises its dividend faster. Which stock wins?

Medtronic pays more today. Abbott raises its dividend faster. Which stock wins? Both are Dividend Kings with decades of consecutive raises, but Medtronic and Abbott reward income investors in fundamentally different ways, and choosing the wrong one in retirement could cost you more than you expect. Medtronic (NYSE:MDT | MDT Price Prediction) or Abbott Laboratories (NYSE:ABT): which medical device dividend stock better suits income needs in retirement? Both stocks outperformed competitors on a strong trading day Monday, but they pay income investors in very different ways. Medtronic offers the higher current payout and covers it with cleaner cash flow. Abbott raises its dividend faster. Medtronic's higher, better-covered yield carries more weight when you live on the checks. Yield: Medtronic pays more per dollar invested. Medtronic's forward annual dividend of $2.88 yields 3.22% with the stock at $91.93. Abbott's forward dividend of $2.52 yields 2.49% at $102.35. Medtronic also costs less: about 15x forward earnings versus 17x for Abbott, and 23x trailing earnings versus 34x. Winner: Medtronic. More income up front, at a lower multiple. Dividend safety: Medtronic's coverage holds up better. On trailing GAAP EPS of $4.07, Medtronic pays out about 70%. Abbott pays out roughly 82% of its $3.03. The $21 billion Exact Sciences acquisition is weighing on Abbott's GAAP results: second-quarter GAAP EPS fell to $0.53 from $1.01, interest expense rose to $299M from $50M, and the company recorded a $385M legal reserve. On adjusted guidance the two look closer. Medtronic's dividend is about 48% of its $5.94 to $6.00 fiscal 2027 guide's low end, and Abbott's is about 46% of its $5.45 to $5.60 range. Free cash flow gives Medtronic the edge. Medtronic generated $5.43B of free cash flow in fiscal 2026, and first-quarter free cash flow of $1.29B covered $921 million in dividends, a payout of roughly 71%. Abbott's cash flow commentary was limited to guidance that cash generation is "likely going to put us ahead of our January forecast for the year." The businesses behind the payouts carry different revenue mixes. Medtronic sells procedure hardware: pacemakers in a Cardiac Rhythm Management unit with more than $5.5 billion in annual revenue, ablation systems growing 88%, a surgical business above $6 billion, and spine robotics. Separating its lower-margin Diabetes unit should lift operating margin by about 100 basis points. Abbott spreads its revenue more widely: devices brought in $5.85B of $12.59B in quarterly revenue, with diagnostics (now including Cologuard), branded generics, and nutrition making up the rest. That diversity helps, but nutrition declined 3.1% and U.S. Structural Heart sales fell 9.8%. Free Report, Just Released Why Didn't ABT Make The Top 10 List? 24/7 Wall St has helped investors make money for over two decades, and our top analysts just finished ranking the definitive Top 10 Stocks To Buy Now. Not the ten biggest companies. Not the ten everyone is arguing about. The ten best stocks to buy right now. And ABT didn't make the cut! The report is free, and you can see why we think each stock is a top investment today. Winner: Medtronic. Dividend growth: Abbott compounds faster. Abbott just made its 54th consecutive year of increases, and Medtronic its 49th, putting both firmly in Dividend King territory (we ranked ten Kings by valuation in a free report). Dividend records back to 1999 show annual raises for both, with one exception: Abbott's quarterly payment fell from $0.51 to $0.14 in 2013, when it spun off AbbVie (NYSE:ABBV). Abbott counts its run as unbroken on a combined basis. Abbott wins easily on pace. Its 2026 raise from $0.59 to $0.63 came to about 6.8%. Medtronic went from $0.71 to $0.72, about 1.4%. Since 2016, Abbott's quarterly payment is up roughly 142%, compared with 67% for Medtronic. Winner: Abbott. Verdict: Medtronic is the retiree's dividend stock. Medtronic wins for retirement-focused income investors. It wins two of the three areas, and those two matter most once you start drawing income: a higher starting yield and cash coverage you can actually see. Its small raises are the weak spot, but the business underlying is speeding up. Fiscal 2026 revenue rose 8.43%, and management raised its fiscal 2027 organic growth guide to 7.25% to 7.75%. With the margin lift from the Diabetes separation on top, Medtronic has room to raise faster. Abbott suits investors with 15 or more years before retirement who reinvest their dividends. Its price return of 200.92% over ten years crushes Medtronic's 45.41%, and a 21.01% drop over the past year leaves the stock below its old highs. For income you need now, though, Medtronic pays more and covers it better. Got $1,000? Before you buy ABT, read this. If you have cash sitting in your account right now, give this two minutes. After more than two decades of helping investors beat the market, our top analysts at 24/7 Wall St. put together a definitive report on the Top 10 Stocks To Buy Today. And ABT wasn't one of them. They combed the entire market. It's not 10 ideas, not 10 stocks everyone is talking about, it's what their research points to as the 10 best stocks to buy right now, and it's free. Read more here and see which stocks made the list ->> Chris Lange Chris Lange is a financial and geopolitical writer with more than a decade of experience covering a myriad of topics. He has published thousands of articles for 24/7 Wall St., with past coverage focused heavily on stocks, IPOs, healthcare, defense, global affairs, and technology. His work has been quoted, or referenced by a number of outlets including Business Insider, USA Today, Yahoo Finance, MSN, The Motley Fool, and many other publications. A graduate of Southwestern University, he studied business with a focus on investments and has previous experience in banking and startups. When not reading or writing the news, he is following his passion for Lacrosse, playing chess, or building solar projects with his dad.

The Healthcare Technology Report

Oct 12th, 2026

Medtronic hires former Recor CEO Lara Barghout to lead Cardiology unit.

Medtronic hires former Recor CEO Lara Barghout to lead Cardiology unit. Published. October 12, 2026 Medtronic has put former Recor Medical chief executive Lara Barghout in charge of its Interventional Cardiology Therapies business, bringing in a leader who previously oversaw a competing hypertension device. Her remit covers structural heart, coronary, and hypertension management products. During her Recor tenure, the Paradise device became the first renal denervation system to receive FDA approval for uncontrolled high blood pressure, MedTech Dive reported. Medtronic's competing Symplicity Spyral secured approval weeks later. "Lara brings proven leadership in the cardiovascular space," Medtronic told MedTech Dive in an emailed statement. Her appointment follows a reorganization dividing the cardiovascular portfolio into four businesses, including the unit she now leads. Earlier roles included senior vice president and head of advanced therapies at Siemens Healthineers and an executive position at Terumo Cardiovascular. She joined Recor as president and chief executive in January 2023 and left in February 2026. Other leadership changes preceded the hire. Jason Fontana, formerly vice president and general manager of renal denervation, announced his departure. Jason Weidman, previously president of coronary and renal denervation, left in the spring to become Teleflex CEO.

Yahoo Finance

Oct 11th, 2026

Medtronic trades at 14.4x forward earnings as quarterly revenue jumps 13.7% to $9.8B

Medtronic shares have fallen more than 7% in the past 12 months, while the broader market gained 17%. At $86.38, the stock trades at a forward price-to-earnings ratio of about 14.4. The medical-device maker raised its fiscal 2027 outlook in September. It now expects organic revenue growth of 7.25% to 7.75% and non-GAAP diluted earnings per share of $5.94 to $6.00. First-quarter organic revenue rose 13.7% to $9.8 billion. Cardiovascular grew 18.9%, diabetes 14.9%, and neuroscience 9.3%. However, an extra fiscal week added about $570 million to organic growth, flattering the result. Whether the momentum lasts will decide if the stock re-rates.

Medtronic

HR Shared Services Specialist - Benefits Operations, Tier II

About the job